Then, in SCLC, CARM1 was found to regulate SMAD7 methylation to activate TGF-β/SMAD signalling, promoting EMT and chemoresistance (Zheng et al., 2021) (Table 2). Here, TGFB1 is linked to small cell lung carcinoma.